Brooke serves on the Boards of eHealth, Inc (NASDAQ:EHTH) and other private companies, in addition to the United States Olympic and Paralympic Committee. This unique experience, combined with her advocacy for diversity and inclusiveness, will be vitally important in guiding our purpose and mission at Beta Bionics, acting in the best possible interest of all people living with type 1 diabetes." "Throughout her career, Beth has helped shape public health policy through her strategic leadership in both the public and private sectors. Her fierce commitment to egalitarianism, opportunity, diversity, and innovation is perfectly aligned with the core principles and values of our benefit mission at Beta Bionics," said Ed Damiano, President and Chief Executive Officer of Beta Bionics. "We are so pleased to have Beth join our Board of Directors at Beta Bionics. a medical technology company developing the iLet ®, the world’s first fully automated bionic pancreas system - today announced that Beth Brooke has been appointed to the Company’s Board of Directors. Since its founding in 2015, its mission has been to help improve health outcomes and the quality of life of all children and adults living with diabetes and other conditions of glycemic dysregulation.īeta Bionics operates in Massachusetts and California.Beta Bionics, Inc. The iLet’s simple user interface, together with its automated, adaptive control algorithms, is designed to eliminate many of the cumbersome tasks of diabetes management in order to decrease the cognitive and emotional burden of living with diabetes.īeta Bionics is a for-profit, public benefit corporation and Certified B Corporation™.
![facebook beta bionics facebook beta bionics](https://www.bu.edu/files/2016/04/v_research_16-9888-PRATT-027.jpg)
![facebook beta bionics facebook beta bionics](https://www.goodnewsnetwork.org/wp-content/uploads/2019/12/iLet-Bionic-Pancreas-Freethink-Youtube-Screenshot.jpg)
The iLet bionic pancreas features an intuitive user interface, which only requires the input of a patient’s body weight to initiate dosing. The iLet bionic pancreas is designed to use adaptive control algorithms, together with continuous glucose monitoring and pump technology, to autonomously compute and administer all doses of either insulin or glucagon or both and mimic the body’s natural ability to maintain tight glycemic control. Jones is an Aspen Institute Henry Crown Fellow and received her Master of Business Administration from Harvard Business School and a Bachelor of Arts in Economics from Stanford University.īeta Bionics ® is a medical device company focused on the design, development, and commercialization of its iLet bionic pancreas system, which has the potential to be a revolutionary solution for people with diabetes on intensive insulin therapy. Jones has been honored as Ernst and Young’s “National Young Entrepreneur of the Year”, a “Top 100 Young Innovator” by MIT’s Technology Review, and “Top 20 Leaders Under 30” by Working Woman.
#Facebook beta bionics software#
She is also the co-founder of Trilogy Software and served as the President and Founder of pcOrder, which she successfully led from start-up to a NASDAQ-listed public corporation. She previously served on the board of Optiva, Inc. Jones is Managing Director of Richmond Capital Partners and serves on the board of Extend Fertility, which she founded in 2004. I look forward to helping the team drive the company’s public benefit mission forward as we work to create a solution that will improve the quality of life for people with diabetes,” said Ms. “I am excited for the opportunity to work alongside such a passionate and mission-driven organization. Her unique experience as a founder and CEO of both public and private companies in the health sciences and tech sectors, will be invaluable in guiding our mission to bring the iLet to as many people with diabetes as possible.”
![facebook beta bionics facebook beta bionics](https://marvel-b1-cdn.bc0a.com/f00000000243109/1x5o5mujiug388ttap1p8s17-wpengine.netdna-ssl.com/wp-content/uploads/2020/12/SFC-Patch-Pump-1200x800-1.jpg)
“Christy is a highly respected entrepreneur with a successful track record of bringing new technologies to market. “We are delighted to welcome Christy to our Board of Directors,” commented Ed Damiano, President and Chief Executive Officer. IRVINE, Calif., (GLOBE NEWSWIRE) - Beta Bionics, Inc., a medical technology company focused on the design, development, and commercialization of the iLet ® bionic pancreas system, today announced the appointment of Christy Jones to its Board of Directors.